S4 E25, Dr. Nerissa Kreher - Chief Medical Officer of Alltrna

<p>Reimagining Rare Disease Drug Development with Nerissa Kreher</p><p><br></p><p>In this episode of <em>She Leads Biotech</em>, I’m joined by Nerissa Kreher, Chief Medical Officer of Alltrna, for a conversation about rare disease innovation, precision medicine, and the future of drug development.</p><p>With more than 20 years of experience in rare diseases, Nerissa shares her journey from pediatric endocrinologist to biotech executive and explains how Alltrna is taking a novel approach to treating genetic diseases through mutation-defined therapies.</p><p>A fascinating discussion about science, innovation, leadership, and hope for families living with rare diseases.</p><p><strong>Chapters</strong></p><p>00:00 Introduction<br>02:00 From Medicine to Biotech<br>05:00 Falling in Love with Rare Disease Research<br>08:00 Understanding Rare Disease Communities<br>12:00 The Challenge of Clinical Trials in Rare Diseases<br>16:00 Mutation-Defined Therapies Explained<br>21:00 How Alltrna Is Rethinking Drug Development<br>26:00 Regulatory &amp; Clinical Development Challenges<br>31:00 Public vs Private Company Leadership<br>35:00 What Makes a Great Biotech Executive<br>39:00 Leadership, Mentorship &amp; Authenticity<br>43:00 The Role of Patients in Drug Development<br>47:00 The Future of Rare Disease Innovation<br>51:00 Bringing Hope to Patients &amp; Families</p><p><br></p><p>#SheLeadsBiotech #RareDisease #PrecisionMedicine #GeneTherapy #BiotechLeadership #WomenInBiotech #CNAUSAExecutiveSearch</p><p></p>